当前位置: 首页 > 详情页

Loss of microRNA-30e induced by extracellular vesicles from cancer-associated fibroblasts promotes breast cancer progression by binding to CTHRC1

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE ◇ 预警期刊

机构: [1]Department of General Surgery, Xuanwu Hospital, Capital Medical University, Beijing 100053, PR China. [2]Department of Breast Surgery, Shanxi Provincial People's Hospital, Taiyuan 030012, Shanxi, PR China. [3]Department of Surgery Lab, Xuanwu Hospital, Capital Medical University, Beijing 100053, PR China.
出处:
ISSN:

关键词: Breast cancer Cancer-associated fibroblasts Collagen triple helix repeat containing 1 Extracellular vesicles microRNA-30e Wnt/β-catenin pathway

摘要:
Breast cancer (BC) is a frequently occurring malignancy within female population. Recently, the significance of extracellular vesicles (EVs) derived from cancer-associated fibroblasts (CAF) (CAF-EVs) in malignancies has been increasingly recognized. The study aims to explore the functional mechanism of CAF-EVs in the development of BC. Initially, EVs were isolated from CAF, followed by observation on morphological change using transmission electronic microscope. Next, BC and the adjacent normal tissues were collected for quantification of microRNA (miR)-30e and collagen triple helix repeat containing 1 (CTHRC1) using RT-qPCR and Western blot analysis. miR-30e was downregulated in BC, while CTHRC1 was upregulated. Luciferase assay revealed that miR-30e targeted CTHRC1. miR-30e and CTHRC1 expression was altered to evaluate their effects on BC cell viabilities in vitro. It was shown that overexpression of miR-30e or silencing of CTHRC1 suppressed proliferation, migration/invasion of BC cells but promoted apoptosis. Xenograft tumors were developed in mice to observe the tumorigenesis. To sum up, CAF-EVs reduced miR-30e expression to upregulate CTHRC1, which aggravated BC in vitro and in vivo. © 2020 Elsevier Inc.

语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2020]版:
大类 | 3 区 医学
小类 | 3 区 病理学
最新[2023]版:
大类 | 4 区 医学
小类 | 3 区 病理学
JCR分区:
出版当年[2019]版:
Q2 PATHOLOGY
最新[2023]版:
Q2 PATHOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2019版] 出版当年五年平均 出版前一年[2018版] 出版后一年[2020版]

第一作者:
第一作者机构: [1]Department of General Surgery, Xuanwu Hospital, Capital Medical University, Beijing 100053, PR China. [2]Department of Breast Surgery, Shanxi Provincial People's Hospital, Taiyuan 030012, Shanxi, PR China.
通讯作者:
通讯机构: [*1]Department of General Surgery, Xuanwu Hospital, Capital Medical University, Beijing 100053, PR China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16461 今日访问量:0 总访问量:871 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院